Lange HH - Search Results

1

Inhibition of metalloproteinases enhances the internalization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunotoxin.

Hansen HP, Matthey B, Barth S, Kisseleva T, Mokros T, Davies SJ, Beckett RP, Foelster-Holst R, Lange HH, Engert A, Lemke H. Hansen HP, et al. Among authors: lange hh. Int J Cancer. 2002 Mar 10;98(2):210-5. doi: 10.1002/ijc.10182. Int J Cancer. 2002. PMID: 11857410

2

Metalloproteinase inhibition augments antitumor efficacy of the anti-CD30 immunotoxin Ki-3(scFv)-ETA' against human lymphomas in vivo.

Matthey B, Borchmann P, Schnell R, Tawadros S, Lange H, Huhn M, Klimka A, Tur MK, Barth S, Engert A, Hansen HP. Matthey B, et al. Int J Cancer. 2004 Sep 10;111(4):568-74. doi: 10.1002/ijc.20278. Int J Cancer. 2004. PMID: 15239135

3

CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme.

Hansen HP, Dietrich S, Kisseleva T, Mokros T, Mentlein R, Lange HH, Murphy G, Lemke H. Hansen HP, et al. Among authors: lange hh. J Immunol. 2000 Dec 15;165(12):6703-9. doi: 10.4049/jimmunol.165.12.6703. J Immunol. 2000. PMID: 11120787

4

Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).

Horn-Lohrens O, Tiemann M, Lange H, Kobarg J, Hafner M, Hansen H, Sterry W, Parwaresch RM, Lemke H. Horn-Lohrens O, et al. Int J Cancer. 1995 Feb 8;60(4):539-44. doi: 10.1002/ijc.2910600419. Int J Cancer. 1995. PMID: 7530238

5

The ectodomain shedding of CD30 is specifically regulated by peptide motifs in its cysteine-rich domains 2 and 5.

Hansen HP, Recke A, Reineke U, Von Tresckow B, Borchmann P, Von Strandmann EP, Lange H, Lemke H, Engert A. Hansen HP, et al. FASEB J. 2004 May;18(7):893-5. doi: 10.1096/fj.03-0901fje. Epub 2004 Mar 19. FASEB J. 2004. PMID: 15033921

6

Depletion of cellular cholesterol and lipid rafts increases shedding of CD30.

von Tresckow B, Kallen KJ, von Strandmann EP, Borchmann P, Lange H, Engert A, Hansen HP. von Tresckow B, et al. J Immunol. 2004 Apr 1;172(7):4324-31. doi: 10.4049/jimmunol.172.7.4324. J Immunol. 2004. PMID: 15034047

7

Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen.

Schnell R, Linnartz C, Katouzi AA, Schön G, Bohlen H, Horn-Lohrens O, Parwaresch RM, Lange H, Diehl V, Lemke H, et al. Schnell R, et al. Int J Cancer. 1995 Oct 9;63(2):238-44. doi: 10.1002/ijc.2910630216. Int J Cancer. 1995. PMID: 7591211

8

Generalization of single immunological experiences by idiotypically mediated clonal connections.

Lemke H, Lange H. Lemke H, et al. Adv Immunol. 2002;80:203-41. doi: 10.1016/s0065-2776(02)80016-5. Adv Immunol. 2002. PMID: 12078482 Review.

9

Cellular localizations and processing of the two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen. The protein kinase Ki-1/57 occurs in the nucleus.

Rohde D, Hansen H, Hafner M, Lange H, Mielke V, Hansmann ML, Lemke H. Rohde D, et al. Am J Pathol. 1992 Feb;140(2):473-82. Am J Pathol. 1992. PMID: 1310832 Free PMC article.

10

Induction of a non-oscillating, long-lasting humoral immune response to an internal network antigen.

Lange H, Lemke H. Lange H, et al. Int Immunol. 1996 May;8(5):683-8. doi: 10.1093/intimm/8.5.683. Int Immunol. 1996. PMID: 8671655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters